20 Israeli Health tech Companies Showcase Breakthrough Medical Technologies at GoforIsrael U.S. Debut in Miami
The international investment conference GoforIsrael will spotlight 20 Israeli Life Sciences/Healthtech companies at its first-ever U.S. edition, taking place March 16, 2026, in Miami Beach. The event will bring together innovative startup founders with global investors, healthcare leaders, strategic partners, and decision-makers for a full day of curated meetings, panels, and start-ups presentations — with a strong focus on breakthrough Israeli innovation in biotech, medtech, and pharma.
Among the featured companies:
CAPS Medical is a clinical-stage MedTech company developing PlasmaSure™, a first-in-class non-thermal plasma system designed for selective, minimally invasive ablation of solid tumors. Its platform has received FDA Breakthrough Device Designation for the treatment of low to intermediate-risk non-muscle invasive bladder cancer (NMIBC), following successful first-in-human clinical results demonstrating strong safety and durable response rates. The company is preparing for pivotal U.S. trials and commercialization.
NaNose Medical is pioneering a non-invasive, breath-based technology, to enable early risk detection of lung and liver cancer. These diseases are in the top three deadliest cancers in the world, simply because we catch it way too late. The company’s breakthrough approach is based on a simple breath test that anyone can take, delivering rapid and convenient early detection of cancer and pre-cancerous conditions for which optimal diagnostic solutions are still lacking. The company will launch on March 12 its first US based clinical trial at Jefferson Health (Philadelphia).
Cytora is a clinical‑stage biotech company developing a first‑in‑class, off‑the‑shelf cell therapy platform based on human oral mucosa stem cells (hOMSCs), a neural‑crest‑derived allogeneic cell population. The platform has already demonstrated a favorable safety profile and promising signs of efficacy in two programs: hOMSC200 for hard‑to‑heal diabetic foot ulcers and hOMSC300 for multiple system atrophy, where early data suggest a potential slowing of disease progression. The company has entered into strategic partnerships with Made Scientific, a US‑based CDMO, and Zeo ScientifiX, a Florida‑based clinical‑stage company, to advance and commercialize Cytora’s novel allogeneic, off‑the‑shelf human oral mucosa stem cell therapy in Florida.
OrthoTreat is developing the first dual drug therapeutic platform for bone regeneration based on a proprietary concept called Osteoregulation. The technology is designed to actively regulate the full biological ecosystem governing bone regeneration, including the immune-inflammatory environment and the balance between osteoblast-driven bone formation and osteoclast-mediated bone resorption. By restoring this biological balance, OrthoTreat aims to improve both the speed and quality of bone healing.
FIZE Medical has developed an AI-driven, real-time fluid management platform for intensive care units, aimed at preventing patient deterioration before irreversible damage occurs. First release of the technology is already in clinical use in Israel, the U.S., and soon in Japan.
“Additional companies that will be showcasing their innovations are: BlinkAid, Cell-Lipo, CervInsight, Curalife, Imma Health, LaserTeam, Naya Therapeutics, Nina Medical, , Picodya, Remedy Cell, , UltraSight, Venocare, and additional emerging innovators.
“Israel continues to deliver world-class innovation in life sciences and medical technologies that address urgent global health challenges,” said Dr. Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences. “Bringing GoForIsrael to Miami connects U.S. and international investors with curated, investment-ready Israeli healthcare companies in one focused day.”
For media inquiries and interview coordination:
Omer Hochbaum
Positive Communications – Media Contact, GoForIsrael
